Stimuli-free programmable drug release for combination chemo-therapy

Nanoscale

Volumn 8, Issue 25, 2016, Pages 12553-12559

  Fan, Li ^a,b   Jin, Boquan ^a   Zhang, Silu ^b   Song, Chaojun ^a   Li, Quan ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DISEASES;

COLON CANCER CELLS; COMBINATION CHEMOTHERAPY; DRUG LOADED NANOPARTICLE; EFFECTIVE APPROACHES; EXTERNAL STIMULUS; NANOPARTICULATE SYSTEM; SEQUENTIAL MANNERS; SYNERGISTIC EFFECT;

TUMORS;

ANTINEOPLASTIC AGENT; DOXORUBICIN; METHYLENE BLUE; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL; BAGG ALBINO MOUSE; DRUG DELIVERY SYSTEM; DRUG RELEASE; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; FEMALE; HUMANS; METHYLENE BLUE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; SILICON DIOXIDE;

EID: 84976367326     PISSN: 20403364     EISSN: 20403372     Source Type: Journal    
DOI: 10.1039/c5nr06305a     Document Type: Article

References (25)

1. C. M. Hu S. Aryal L. Zhang Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment Ther. Delivery 2010 1 323 334
2. G. Bonadonna E. Brusamolino P. Valagussa A. Rossi L. Brugnatelli C. Brambilla M. De Lena G. Tancini E. Bajetta R. Musumeci et al. Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer N. Engl. J. Med. 1976 294 405 410
3. J. Lehar A. S. Krueger W. Avery A. M. Heilbut L. M. Johansen E. R. Price R. J. Rickles G. F. Short 3rd J. E. Staunton X. Jin et al. Synergistic Drug Dombinations Tend to Improve Therapeutically Relevant Selectivity Nat. Biotechnol. 2009 27 659 666
4. L. C. Hull D. Farrell P. Grodzinski Highlights of Recent Developments and Trends in Cancer Nanotechnology Research-view from NCI Alliance for Nanotechnology in Cancer Biotechnol. Adv. 2014 32 666 678
5. H. Chen Y. Zhao H. Wang G. Nie K. Nan Co-delivery Strategies Based on Multifunctional Nanocarriers for Cancer Therapy Curr. Drug Metab. 2012 13 1087 1096
6. D. B. Pacardo F. S. Ligler Z. Gu Programmable Nanomedicine Synergistic and Sequential Drug Delivery Systems Nanoscale 2015 7 3381 3391
7. S. Mitragotri P. A. Burke R. Langer Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies Nat. Rev. Drug Discovery 2014 13 655 672
8. S. W. Morton M. J. Lee Z. J. Deng E. C. Dreaden E. Siouve K. E. Shopsowitz N. J. Shah M. B. Yaffe P. T. Hammond A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways Sci. Signaling. 2014 7 ra44
9. N. S. Gandhi R. K. Tekade M. B. Chougule Nanocarrier Mediated Delivery of SiRNA/miRNA in Combination with Chemotherapeutic Agents for Cancer Therapy: Current Progress and Advances J. Controlled Release 2014 194 238 256
10. V. P. Torchilin Multifunctional, Stimuli-Sensitive Nanoparticulate Systems for Drug Delivery Nat. Rev. Drug Discovery 2014 13 813 827
11. E. K. Lim E. Jang K. Lee S. Haam Y. M. Huh Delivery of Cancer Therapeutics Using Nanotechnology Pharmaceutics 2013 5 294 317
12. J. Gao W. Zhong J. He H. Li H. Zhang G. Zhou B. Li Y. Lu H. Zou G. Kou et al. Tumor-Targeted PE38KDEL Delivery via PEGylated Anti-HER2 Immunoliposomes Int. J. Pharm. 2009 374 145 152
13. K. B. Sutradhar M. L. Amin Nanotechnology in Cancer Drug Delivery and Selective Targeting ISRN Nanotechnol. 2014 2014 1 12
14. K. Park Nanotechnology: What It Can Do for Drug Delivery J. Controlled Release 2007 120 1 3
15. Y. Li L. Yang Driving Forces for Drug Loading in Drug Carriers J. Microencapsulation 2015 3 1 18
16. H. J. Hah G. Kim Y. K. Lee D. A. Orringer O. Sagher M. A. Philbert R. Kopelman Methylene Blue-Conjugated Hydrogel Nanoparticles and Tumor-CellTargeted Photodynamic Therapy Macromol. Biosci. 2011 11 90 99
17. W. M. Sharman C. M. Allen J. E. van Lier Photodynamic therapeutics: basic principles and clinical applications Drug Discovery Today 1999 4 507 517
18. H. Mohr B. Lambrecht A. Selz Photodynamic Virus Inactivation of Blood Components Immunol. Invest. 1995 24 73 85
19. H. Mohr B. Lambrecht H. Schmitt German Red Cross Blood Transfusion Service Lower Saxony, Institute Springe Dev. Biol. Stand. 1993 81 177 183
20. S. J. Wagner D. Robinette J. Storry X. Y. Chen J. Shumaker L. Benade Differential sensitivities of viruses in red cell suspensions to methylene blue photosensitization Transfusion 1994 34 521 526
21. A. J. Matisoff M. K. Panni Methylene blue treatment for methemoglobinemia and subsequent dramatic bispectral index reduction Anesthesiology 2006 105 228
22. P. Ma R. J. Mumper Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review Nano Today 2013 8 313 331
23. 2-Drug Composite Nanoparticles J. Am. Chem. Soc. 2013 135 5709 5716
24. J. Legault P. L. Larouche I. Cote L. Bouchard A. Pichette B. H. Robinson C. Morin Low-Concentration Methylene Blue Maintains Energy Production and Strongly Improves Survival of Leigh Syndrome French Canadian Skin Fibroblasts J. Pharm. Pharm. Sci. 2011 14 438 449
25. P. Pileri, S. Campagnoli, A. Grandi, M. Parri, E. D. Camilli, C. Song, I. Naldi, P. Sarmientos, C. Cinti, B. Jin, G. Grandi, G. Viale, L. Terracciano and R. Grifantini, FAT1: a target for monoclonal antibody therapy in colon cancer. Submitted